Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) Invested Capital (2016 - 2025)

Historic Invested Capital for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to $408.1 million.

  • Cross Country Healthcare's Invested Capital fell 481.56% to $408.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.1 million, marking a year-over-year decrease of 481.56%. This contributed to the annual value of $423.4 million for FY2024, which is 1076.52% down from last year.
  • As of Q3 2025, Cross Country Healthcare's Invested Capital stood at $408.1 million, which was down 481.56% from $412.2 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Invested Capital ranged from a high of $486.1 million in Q2 2023 and a low of $173.7 million during Q1 2021
  • In the last 5 years, Cross Country Healthcare's Invested Capital had a median value of $423.4 million in 2024 and averaged $393.6 million.
  • In the last 5 years, Cross Country Healthcare's Invested Capital skyrocketed by 11390.75% in 2022 and then plummeted by 1145.06% in 2025.
  • Over the past 5 years, Cross Country Healthcare's Invested Capital (Quarter) stood at $305.0 million in 2021, then surged by 50.47% to $459.0 million in 2022, then rose by 3.37% to $474.4 million in 2023, then fell by 10.77% to $423.4 million in 2024, then dropped by 3.6% to $408.1 million in 2025.
  • Its Invested Capital was $408.1 million in Q3 2025, compared to $412.2 million in Q2 2025 and $418.2 million in Q1 2025.